The trial showed that there was a slight but increased risk in preterm labor as well as an increase in neonatal death in the group of very small numbers.
#RSVvaccines #Pregnancy #Vaccines #GlaxoSmithKline
https://www.medscape.com/viewarticle/risk-preterm-birth-stops-maternal-rsv-vaccine-trial-2024a10004rk?form=fpf
#RSVvaccines #Pregnancy #Vaccines #GlaxoSmithKline
https://www.medscape.com/viewarticle/risk-preterm-birth-stops-maternal-rsv-vaccine-trial-2024a10004rk?form=fpf
Medscape
Risk for Preterm Birth Stops Maternal RSV Vaccine Trial
With a maternal vaccine already on the market to protect newborns from RSV, the outlook for another looked promising, but latest phase 3 trial of a new candidate is now halted over safety concerns.